We have observed
12 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 26, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTI-ANGIOGENIC AGENT AND METHOD OF USING SUCH AGENT
METHOD AND DEVICE FOR PLASMA-TREATING WORKPIECES
METHOD FOR THE PLASMA TREATMENT OF WORKPIECES AND WORKPIECE WITH A GAS BARRIER LAYER
A METHOD FOR THE PRODUCTION OF HYBRIDOMA CELL LINES PRODUCING MONOCLONAL ANTIBODIES CAPABLE TO SPECIFICALLY BINDING TO A HUMAN C44-FRAGMENT OF AGRIN
Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin
Method for the detection and classification of PRRSV-infections in swine herds and diagnostic antigen compositions for such methods
METHOD FOR THE DETERMINATION OF RENAL FUNCTION
PROTEIN TO PROMOTE BLOOD VESSEL GROWTH AND USES THEREOF
Pressure-stable packaging container for foodstuffs
SAMPLING DEVICE FOR SAMPLES CONTAINING DNA IN PARTICULAR
METHOD FOR THE TREATMENT OF ANIMAL AND VEGETABLE WAXES
FILTER FOR A FEEDING SYSTEM FOR LIQUIDS WITH TENDENCY TO FORM SEDIMENTS, IN PARTICULAR FOR A CRUDE OIL WASHING SYSTEM